Generic drug markets are set to grow to over $700 billion by 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India and China's manufacturing power, and tech-driven efficiency are reshaping global healthcare affordability.
©2026 heydoctor.su. All rights reserved